14 BhagavanH
*Correspondence: Jun Li, [email protected]
Hannah Jeon is an Associate Commerce Editor at Prevention, where she covers expert-driven commerce content for all things health, beauty, and wellness
In a 72-week trial in adults with obesity without diabetes, the mean percentage change in weight was -15.0% (5 mg), -19.5% (10 mg), and -20.9% (15 mg) vs -3.1% with placebo
If you believe you or a loved one have suffered vision loss (NAION) potentially due to use of weight loss / diabetes drugs, call (855)-652-2049 for a FREE case review
The average proportion of GLP-1 claims that were rejected rose from 30% before Wegovys launch, to 41% after Mounjaro hit the market, reflecting a change in the underlying access profile of GLP-1s for patients